Helping scientists to discover new therapeutics faster
Today’s sophisticated LC/MS technologies give you new levels of sensitivity that can dramatically improve your understanding of a small molecule drug or biotherapeutic.
Easy access to these complex technologies can be the key to faster drug discovery.
Whether you are a medicinal chemist or a biologist, Agilent’s open access Mass Hunter Walkup software enables you to leverage leading-edge LC/MS, TOF, and Q-TOF data, which can make a profound difference in understanding the viability of a new drug candidate.
This easy-to-manage platform frees you to focus on what you do best.
Hear users talk about their experiences with MassHunter Walkup software in these webinars: